SlideShare una empresa de Scribd logo
1 de 40
Descargar para leer sin conexión
Incretin Based Therapy of Type 2 Diabetes Mellitus BY Prof. ADEL A EL-SAYED MD Prof. of Internal Medicine Sohag Faculty of Medicine SOHAG EGYPT
Pathophysiology of Type 2 Diabetes  ,[object Object],[object Object]
Pathophysiology of Type 2 Diabetes Insulin Resistance ,[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   Beta cell defect ,[object Object],[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   Beta cell defect ,[object Object],[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   Beta cell defect ,[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   Other Factors ,[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   Other Factors ,[object Object],[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   The Glucagon Factor ,[object Object],[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   The Glucagon Factor ,[object Object],[object Object],[object Object],[object Object]
 
Pathophysiology of Type 2 Diabetes   The Gastric Emptying Factor ,[object Object],[object Object],[object Object]
Pathophysiology of Type 2 Diabetes   One last observation ,[object Object],[object Object],[object Object],[object Object]
What are incretins? ,[object Object],[object Object],[object Object]
What are incretins? Gastric Inhibitory Polypeptide (GIP)   ,[object Object]
What are incretins?   Glucagon-like peptide-1 (GLP-1)  ,[object Object],[object Object],[object Object]
Actions of GLP-1 ,[object Object],[object Object],[object Object],[object Object],[object Object]
Actions of GLP-1 ,[object Object],[object Object],[object Object],[object Object]
Actions of GLP-1 ,[object Object]
 
Actions of GLP-1   The Problem ,[object Object]
The solution ,[object Object],[object Object],[object Object]
Incretin mimetics Exenatide   ,[object Object],[object Object],[object Object],[object Object]
 
Incretin mimetics Exenatide ,[object Object],[object Object],[object Object]
 
Clinical Trials of Exenatide   ,[object Object],[object Object],[object Object]
 
Weight Loss With Exenatide   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Nausea With Exenatide   ,[object Object],[object Object]
Incretin mimetics   Recent Advances ,[object Object],[object Object]
Dipeptidyl Peptidase-IV Antagonists   ,[object Object],[object Object],[object Object],[object Object],[object Object]
 
Dipeptidyl Peptidase-IV Antagonists   Sitagliptin and Vildagliptin ,[object Object],[object Object],[object Object],[object Object]
Dipeptidyl Peptidase-IV Antagonists   Recent Advances ,[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object],[object Object]
 
THANK YOU

Más contenido relacionado

La actualidad más candente

Sglt2 inhibitors past present and future
Sglt2 inhibitors past present and futureSglt2 inhibitors past present and future
Sglt2 inhibitors past present and futurePriyanka Thakur
 
Sodium glucose cotransporter 2 (sglt2) inhibitors
Sodium glucose cotransporter 2 (sglt2) inhibitorsSodium glucose cotransporter 2 (sglt2) inhibitors
Sodium glucose cotransporter 2 (sglt2) inhibitorsMoh'd sharshir
 
Newer anti diabetic drugs
Newer anti diabetic drugsNewer anti diabetic drugs
Newer anti diabetic drugsDr.Vijay Talla
 
An Update On Dpp 4 Inhibitors In The Management Of Type 2 Diabetes
An Update On Dpp 4 Inhibitors In The Management Of Type 2 DiabetesAn Update On Dpp 4 Inhibitors In The Management Of Type 2 Diabetes
An Update On Dpp 4 Inhibitors In The Management Of Type 2 DiabetesPk Doctors
 
Dpp4i earlier the better ! (1)
Dpp4i  earlier the better ! (1)Dpp4i  earlier the better ! (1)
Dpp4i earlier the better ! (1)Faraz Farishta
 
SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:
SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:
SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:Naina Mohamed, PhD
 
Sglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseasesSglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseasesYogesh Shilimkar
 
Dyslipidemia in diabetes
Dyslipidemia in diabetesDyslipidemia in diabetes
Dyslipidemia in diabetesMohsen Eledrisi
 
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insightDipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insightRxVichuZ
 
Semaglutide: The First Oral Glucagon-like Peptide 1 Agonist
Semaglutide: The First Oral Glucagon-like Peptide 1 AgonistSemaglutide: The First Oral Glucagon-like Peptide 1 Agonist
Semaglutide: The First Oral Glucagon-like Peptide 1 Agonistasclepiuspdfs
 

La actualidad más candente (20)

Dpp4 inhibitors
Dpp4  inhibitorsDpp4  inhibitors
Dpp4 inhibitors
 
DPP4 Inhibitors P4 Seminar2
DPP4 Inhibitors P4 Seminar2DPP4 Inhibitors P4 Seminar2
DPP4 Inhibitors P4 Seminar2
 
Sglt2 inhibitors past present and future
Sglt2 inhibitors past present and futureSglt2 inhibitors past present and future
Sglt2 inhibitors past present and future
 
Sodium glucose cotransporter 2 (sglt2) inhibitors
Sodium glucose cotransporter 2 (sglt2) inhibitorsSodium glucose cotransporter 2 (sglt2) inhibitors
Sodium glucose cotransporter 2 (sglt2) inhibitors
 
Newer anti diabetic drugs
Newer anti diabetic drugsNewer anti diabetic drugs
Newer anti diabetic drugs
 
Dpp 4 inhibitors
Dpp 4 inhibitorsDpp 4 inhibitors
Dpp 4 inhibitors
 
Vildagliptin
Vildagliptin Vildagliptin
Vildagliptin
 
An Update On Dpp 4 Inhibitors In The Management Of Type 2 Diabetes
An Update On Dpp 4 Inhibitors In The Management Of Type 2 DiabetesAn Update On Dpp 4 Inhibitors In The Management Of Type 2 Diabetes
An Update On Dpp 4 Inhibitors In The Management Of Type 2 Diabetes
 
SGLT2 inhibitor trials
SGLT2 inhibitor trialsSGLT2 inhibitor trials
SGLT2 inhibitor trials
 
Empagliflozin glycemic control and beyond-Dr Shahjada Selim
Empagliflozin glycemic control and beyond-Dr Shahjada SelimEmpagliflozin glycemic control and beyond-Dr Shahjada Selim
Empagliflozin glycemic control and beyond-Dr Shahjada Selim
 
Dpp4i earlier the better ! (1)
Dpp4i  earlier the better ! (1)Dpp4i  earlier the better ! (1)
Dpp4i earlier the better ! (1)
 
SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:
SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:
SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:
 
Sglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseasesSglt 2 inhibiors in cardiovascular diseases
Sglt 2 inhibiors in cardiovascular diseases
 
SGLT-2
SGLT-2 SGLT-2
SGLT-2
 
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada SelimSGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
 
SGLT 2 inhibitors
SGLT 2 inhibitorsSGLT 2 inhibitors
SGLT 2 inhibitors
 
Dyslipidemia in diabetes
Dyslipidemia in diabetesDyslipidemia in diabetes
Dyslipidemia in diabetes
 
Sitagliptin
SitagliptinSitagliptin
Sitagliptin
 
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insightDipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
 
Semaglutide: The First Oral Glucagon-like Peptide 1 Agonist
Semaglutide: The First Oral Glucagon-like Peptide 1 AgonistSemaglutide: The First Oral Glucagon-like Peptide 1 Agonist
Semaglutide: The First Oral Glucagon-like Peptide 1 Agonist
 

Destacado

Incretin Therapy
Incretin TherapyIncretin Therapy
Incretin Therapyko ko
 
ueda2012 -incretin based therapy of type 2 diabetes mellitus_d.adel
ueda2012 -incretin based therapy of type 2 diabetes mellitus_d.adelueda2012 -incretin based therapy of type 2 diabetes mellitus_d.adel
ueda2012 -incretin based therapy of type 2 diabetes mellitus_d.adelueda2015
 
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 InhibitorsThe Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 InhibitorsPHAM HUU THAI
 
Incretin Based Therapy Of Type 2 Diabetes Mellitus 1
 Incretin Based Therapy Of Type 2 Diabetes Mellitus 1 Incretin Based Therapy Of Type 2 Diabetes Mellitus 1
Incretin Based Therapy Of Type 2 Diabetes Mellitus 1Pk Doctors
 
Journal club.......
Journal club.......Journal club.......
Journal club.......Ramesh Nayak
 
Long presentation on mechanism of action of levosimendan 07.11.2014
Long presentation on mechanism of action of levosimendan 07.11.2014Long presentation on mechanism of action of levosimendan 07.11.2014
Long presentation on mechanism of action of levosimendan 07.11.2014Orion Pharma (Global Brand Manager)
 
Glp 1 edffect of cardiovascular system
Glp 1 edffect of cardiovascular systemGlp 1 edffect of cardiovascular system
Glp 1 edffect of cardiovascular systemDr. Lin
 
Pores and cores of new anti diabetic therapy
Pores and cores of new anti diabetic therapyPores and cores of new anti diabetic therapy
Pores and cores of new anti diabetic therapyOsama Almaraghi
 
Innate Immunity06
Innate Immunity06Innate Immunity06
Innate Immunity06guest08e813
 
2003 role of incretins in glucose homeostasis and diabetes
2003 role of incretins in glucose homeostasis and diabetes2003 role of incretins in glucose homeostasis and diabetes
2003 role of incretins in glucose homeostasis and diabetesDr.Mudasir Bashir
 
Diabetes and Cardiovascular Disease
Diabetes and Cardiovascular DiseaseDiabetes and Cardiovascular Disease
Diabetes and Cardiovascular Diseasescsinha
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndromeheyraghul
 
Ndei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes EpidemiologyNdei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes Epidemiologydavid7s
 

Destacado (20)

Incretin Therapy
Incretin TherapyIncretin Therapy
Incretin Therapy
 
GLP1 Role : DM type 2
GLP1 Role : DM type 2GLP1 Role : DM type 2
GLP1 Role : DM type 2
 
Incretins
IncretinsIncretins
Incretins
 
GLP-1 and Diabetes Mellitus
GLP-1 and Diabetes MellitusGLP-1 and Diabetes Mellitus
GLP-1 and Diabetes Mellitus
 
ueda2012 -incretin based therapy of type 2 diabetes mellitus_d.adel
ueda2012 -incretin based therapy of type 2 diabetes mellitus_d.adelueda2012 -incretin based therapy of type 2 diabetes mellitus_d.adel
ueda2012 -incretin based therapy of type 2 diabetes mellitus_d.adel
 
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 InhibitorsThe Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
The Role of SGLT 2 Inhibitors and GLP 1 Receptor Agonists and DPP 4 Inhibitors
 
Incretin Based Therapy Of Type 2 Diabetes Mellitus 1
 Incretin Based Therapy Of Type 2 Diabetes Mellitus 1 Incretin Based Therapy Of Type 2 Diabetes Mellitus 1
Incretin Based Therapy Of Type 2 Diabetes Mellitus 1
 
Journal club.......
Journal club.......Journal club.......
Journal club.......
 
Long presentation on mechanism of action of levosimendan 07.11.2014
Long presentation on mechanism of action of levosimendan 07.11.2014Long presentation on mechanism of action of levosimendan 07.11.2014
Long presentation on mechanism of action of levosimendan 07.11.2014
 
Glp 1 edffect of cardiovascular system
Glp 1 edffect of cardiovascular systemGlp 1 edffect of cardiovascular system
Glp 1 edffect of cardiovascular system
 
Pores and cores of new anti diabetic therapy
Pores and cores of new anti diabetic therapyPores and cores of new anti diabetic therapy
Pores and cores of new anti diabetic therapy
 
Innate Immunity06
Innate Immunity06Innate Immunity06
Innate Immunity06
 
Enrich Programme
Enrich ProgrammeEnrich Programme
Enrich Programme
 
2003 role of incretins in glucose homeostasis and diabetes
2003 role of incretins in glucose homeostasis and diabetes2003 role of incretins in glucose homeostasis and diabetes
2003 role of incretins in glucose homeostasis and diabetes
 
Diabetes and Cardiovascular Disease
Diabetes and Cardiovascular DiseaseDiabetes and Cardiovascular Disease
Diabetes and Cardiovascular Disease
 
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Glucagon-Like Peptide-1 (GLP-1) Receptor AgonistsGlucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Ndei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes EpidemiologyNdei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes Epidemiology
 
Cardiovascular Risk in Diabetes
Cardiovascular Risk in DiabetesCardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes
 
Liraglutide 1
Liraglutide 1Liraglutide 1
Liraglutide 1
 

Similar a Incretin based therapy of type 2 diabetes mellitus 1

incretin based therapy of type 2 diabetes mellitus 1
incretin based therapy of type 2 diabetes mellitus 1incretin based therapy of type 2 diabetes mellitus 1
incretin based therapy of type 2 diabetes mellitus 1SoM
 
Bhavsar et al Curr Diabetes Rev 2013
Bhavsar et al Curr Diabetes Rev 2013Bhavsar et al Curr Diabetes Rev 2013
Bhavsar et al Curr Diabetes Rev 2013Sunil Bhavsar
 
Prospects of incretin mimetics in therapeutics
Prospects of incretin mimetics in therapeuticsProspects of incretin mimetics in therapeutics
Prospects of incretin mimetics in therapeuticsDr Sukanta sen
 
Newer Anti-Hyperglycemic agents in type 2 Diabetes Mellitus e Expanding the h...
Newer Anti-Hyperglycemic agents in type 2 Diabetes Mellitus e Expanding the h...Newer Anti-Hyperglycemic agents in type 2 Diabetes Mellitus e Expanding the h...
Newer Anti-Hyperglycemic agents in type 2 Diabetes Mellitus e Expanding the h...Apollo Hospitals
 
Newer Anti-Hyperglycemic Agents in Type 2 Diabetes Mellitus - Expanding the H...
Newer Anti-Hyperglycemic Agents in Type 2 Diabetes Mellitus - Expanding the H...Newer Anti-Hyperglycemic Agents in Type 2 Diabetes Mellitus - Expanding the H...
Newer Anti-Hyperglycemic Agents in Type 2 Diabetes Mellitus - Expanding the H...Apollo Hospitals
 
Newer anti-hyperglycemic agents in type 2 diabetes mellitus - Expanding the h...
Newer anti-hyperglycemic agents in type 2 diabetes mellitus - Expanding the h...Newer anti-hyperglycemic agents in type 2 diabetes mellitus - Expanding the h...
Newer anti-hyperglycemic agents in type 2 diabetes mellitus - Expanding the h...Apollo Hospitals
 
O futuro na terapia baseada em incretins.
O futuro na terapia baseada em incretins.O futuro na terapia baseada em incretins.
O futuro na terapia baseada em incretins.Ruy Pantoja
 
Ndei Beta Cell Slide Kit Future Therapies
Ndei Beta Cell Slide Kit   Future TherapiesNdei Beta Cell Slide Kit   Future Therapies
Ndei Beta Cell Slide Kit Future TherapiesPPSCME
 
Efecto incretina fisologia
Efecto incretina fisologiaEfecto incretina fisologia
Efecto incretina fisologiayanetguzmanaybar
 
International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
 
Recent advances management of Diabetes Mellitus-Targeting to Gastrointestinal...
Recent advances management of Diabetes Mellitus-Targeting to Gastrointestinal...Recent advances management of Diabetes Mellitus-Targeting to Gastrointestinal...
Recent advances management of Diabetes Mellitus-Targeting to Gastrointestinal...kiflay mulugeta
 
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedUeda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedueda2015
 
Dpp4 beta cell preservation
Dpp4 beta cell preservationDpp4 beta cell preservation
Dpp4 beta cell preservationRuy Pantoja
 

Similar a Incretin based therapy of type 2 diabetes mellitus 1 (20)

incretin based therapy of type 2 diabetes mellitus 1
incretin based therapy of type 2 diabetes mellitus 1incretin based therapy of type 2 diabetes mellitus 1
incretin based therapy of type 2 diabetes mellitus 1
 
Bhavsar et al Curr Diabetes Rev 2013
Bhavsar et al Curr Diabetes Rev 2013Bhavsar et al Curr Diabetes Rev 2013
Bhavsar et al Curr Diabetes Rev 2013
 
Prospects of incretin mimetics in therapeutics
Prospects of incretin mimetics in therapeuticsProspects of incretin mimetics in therapeutics
Prospects of incretin mimetics in therapeutics
 
Newer Anti-Hyperglycemic agents in type 2 Diabetes Mellitus e Expanding the h...
Newer Anti-Hyperglycemic agents in type 2 Diabetes Mellitus e Expanding the h...Newer Anti-Hyperglycemic agents in type 2 Diabetes Mellitus e Expanding the h...
Newer Anti-Hyperglycemic agents in type 2 Diabetes Mellitus e Expanding the h...
 
Newer Anti-Hyperglycemic Agents in Type 2 Diabetes Mellitus - Expanding the H...
Newer Anti-Hyperglycemic Agents in Type 2 Diabetes Mellitus - Expanding the H...Newer Anti-Hyperglycemic Agents in Type 2 Diabetes Mellitus - Expanding the H...
Newer Anti-Hyperglycemic Agents in Type 2 Diabetes Mellitus - Expanding the H...
 
Newer anti-hyperglycemic agents in type 2 diabetes mellitus - Expanding the h...
Newer anti-hyperglycemic agents in type 2 diabetes mellitus - Expanding the h...Newer anti-hyperglycemic agents in type 2 diabetes mellitus - Expanding the h...
Newer anti-hyperglycemic agents in type 2 diabetes mellitus - Expanding the h...
 
O futuro na terapia baseada em incretins.
O futuro na terapia baseada em incretins.O futuro na terapia baseada em incretins.
O futuro na terapia baseada em incretins.
 
Msd Trivandrum Dr Ka
Msd Trivandrum Dr KaMsd Trivandrum Dr Ka
Msd Trivandrum Dr Ka
 
Msd Orissa Apicon Nov 2008 Dr Ka
Msd Orissa Apicon Nov 2008 Dr KaMsd Orissa Apicon Nov 2008 Dr Ka
Msd Orissa Apicon Nov 2008 Dr Ka
 
Ndei Beta Cell Slide Kit Future Therapies
Ndei Beta Cell Slide Kit   Future TherapiesNdei Beta Cell Slide Kit   Future Therapies
Ndei Beta Cell Slide Kit Future Therapies
 
Efecto incretina fisologia
Efecto incretina fisologiaEfecto incretina fisologia
Efecto incretina fisologia
 
International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)
 
Teneligliptin
TeneligliptinTeneligliptin
Teneligliptin
 
Recent advances management of Diabetes Mellitus-Targeting to Gastrointestinal...
Recent advances management of Diabetes Mellitus-Targeting to Gastrointestinal...Recent advances management of Diabetes Mellitus-Targeting to Gastrointestinal...
Recent advances management of Diabetes Mellitus-Targeting to Gastrointestinal...
 
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedUeda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayed
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 
LITERATURE EVALUATION.pdf
LITERATURE EVALUATION.pdfLITERATURE EVALUATION.pdf
LITERATURE EVALUATION.pdf
 
Glp1 clinical view
Glp1 clinical viewGlp1 clinical view
Glp1 clinical view
 
Dpp4 beta cell preservation
Dpp4 beta cell preservationDpp4 beta cell preservation
Dpp4 beta cell preservation
 
diabetes mellitus
 diabetes mellitus diabetes mellitus
diabetes mellitus
 

Más de Pk Doctors

HMS INSTALLATION PROCEDURE
HMS INSTALLATION PROCEDUREHMS INSTALLATION PROCEDURE
HMS INSTALLATION PROCEDUREPk Doctors
 
Management of Bronchial Asthma
Management of Bronchial AsthmaManagement of Bronchial Asthma
Management of Bronchial AsthmaPk Doctors
 
Dr muhammad fiaz
Dr muhammad fiazDr muhammad fiaz
Dr muhammad fiazPk Doctors
 
Dengue fever algorithm and charts
Dengue fever algorithm and chartsDengue fever algorithm and charts
Dengue fever algorithm and chartsPk Doctors
 
Guidelines on clinical management of Dengue Fever & Dengue Hemorrhagic Syndrome
Guidelines on clinical management of Dengue Fever & Dengue Hemorrhagic SyndromeGuidelines on clinical management of Dengue Fever & Dengue Hemorrhagic Syndrome
Guidelines on clinical management of Dengue Fever & Dengue Hemorrhagic SyndromePk Doctors
 
Antenatal care
Antenatal careAntenatal care
Antenatal carePk Doctors
 
Diabetic Neuropathy
Diabetic NeuropathyDiabetic Neuropathy
Diabetic NeuropathyPk Doctors
 
Insulin Therapy in DM
Insulin Therapy in DMInsulin Therapy in DM
Insulin Therapy in DMPk Doctors
 
Diabetes and Pregnancy
Diabetes and PregnancyDiabetes and Pregnancy
Diabetes and PregnancyPk Doctors
 
CBC Interpretition
CBC InterpretitionCBC Interpretition
CBC InterpretitionPk Doctors
 
Asthma management
Asthma managementAsthma management
Asthma managementPk Doctors
 
Dr.S. Abbas Raza
Dr.S. Abbas RazaDr.S. Abbas Raza
Dr.S. Abbas RazaPk Doctors
 
Dr. Huma Arshad
Dr. Huma ArshadDr. Huma Arshad
Dr. Huma ArshadPk Doctors
 
Prof .Atif Kazmi
Prof .Atif KazmiProf .Atif Kazmi
Prof .Atif KazmiPk Doctors
 
Prof Riaz Ahmed
Prof Riaz AhmedProf Riaz Ahmed
Prof Riaz AhmedPk Doctors
 

Más de Pk Doctors (20)

HMS INSTALLATION PROCEDURE
HMS INSTALLATION PROCEDUREHMS INSTALLATION PROCEDURE
HMS INSTALLATION PROCEDURE
 
Coenzyme Q10
Coenzyme Q10Coenzyme Q10
Coenzyme Q10
 
Management of Bronchial Asthma
Management of Bronchial AsthmaManagement of Bronchial Asthma
Management of Bronchial Asthma
 
Dr muhammad fiaz
Dr muhammad fiazDr muhammad fiaz
Dr muhammad fiaz
 
Dengue fever algorithm and charts
Dengue fever algorithm and chartsDengue fever algorithm and charts
Dengue fever algorithm and charts
 
Guidelines on clinical management of Dengue Fever & Dengue Hemorrhagic Syndrome
Guidelines on clinical management of Dengue Fever & Dengue Hemorrhagic SyndromeGuidelines on clinical management of Dengue Fever & Dengue Hemorrhagic Syndrome
Guidelines on clinical management of Dengue Fever & Dengue Hemorrhagic Syndrome
 
Antenatal care
Antenatal careAntenatal care
Antenatal care
 
Diabetic Neuropathy
Diabetic NeuropathyDiabetic Neuropathy
Diabetic Neuropathy
 
COPD
COPDCOPD
COPD
 
Insulin Therapy in DM
Insulin Therapy in DMInsulin Therapy in DM
Insulin Therapy in DM
 
Diabetes and Pregnancy
Diabetes and PregnancyDiabetes and Pregnancy
Diabetes and Pregnancy
 
CBC Interpretition
CBC InterpretitionCBC Interpretition
CBC Interpretition
 
Asthma management
Asthma managementAsthma management
Asthma management
 
Dr.S. Abbas Raza
Dr.S. Abbas RazaDr.S. Abbas Raza
Dr.S. Abbas Raza
 
Dr. Ali java
Dr. Ali javaDr. Ali java
Dr. Ali java
 
Dr. Huma Arshad
Dr. Huma ArshadDr. Huma Arshad
Dr. Huma Arshad
 
Prof .Atif Kazmi
Prof .Atif KazmiProf .Atif Kazmi
Prof .Atif Kazmi
 
Prof Arif
Prof ArifProf Arif
Prof Arif
 
Prof Riaz Ahmed
Prof Riaz AhmedProf Riaz Ahmed
Prof Riaz Ahmed
 
Dr. Ali Joo.
Dr. Ali Joo.Dr. Ali Joo.
Dr. Ali Joo.
 

Último

P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17Celine George
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxMYDA ANGELICA SUAN
 
Benefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationBenefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationMJDuyan
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapitolTechU
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfMohonDas
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17Celine George
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17Celine George
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and stepobaje godwin sunday
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptxSandy Millin
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICESayali Powar
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfMohonDas
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxDr. Asif Anas
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesMohammad Hassany
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesCeline George
 

Último (20)

P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptx
 
Benefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationBenefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive Education
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptx
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdf
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and step
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024
 
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdfPersonal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICE
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdf
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptx
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming Classes
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 Sales
 

Incretin based therapy of type 2 diabetes mellitus 1

  • 1. Incretin Based Therapy of Type 2 Diabetes Mellitus BY Prof. ADEL A EL-SAYED MD Prof. of Internal Medicine Sohag Faculty of Medicine SOHAG EGYPT
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.  
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.  
  • 21.
  • 22.
  • 23.
  • 24.  
  • 25.
  • 26.  
  • 27.
  • 28.  
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.  
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.